The DOI matches its Crossref record, with a small difference in title or year; 59 of the 59 references it cites were found in a registry or an index.
Intravenous iron therapy: how far have we come?
Open accessAbstract
Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia (IDA) because of its effectiveness and low cost. But unfortunately in many iron deficient conditions, oral iron is a less than the ideal treatment mainly because of adverse events related to the gastrointestinal tract as well as the long course required to treat anemia and replenish body iron stores. The first iron product for intravenous use was high-molecular-weight iron dextran. However, dextran-containing intravenous iron preparations are associated with an elevated risk of anaphylactic reactions, which made physicians reluctant to prescribe intravenous iron in the treatment of iron deficiency anemia for many years. In 1999 and 2001, two new intravenous iron preparations (ferric gluconate and iron sucrose) were introduced into the market as safer alternatives to iron dextran. Over the last five years, three new intravenous iron dextran-free preparations have been developed and have better safety profiles than the more traditional intravenous compounds, as none require test doses and all these products are promising in respect to a more rapid replacement of body iron stores (15-60 minutes/infusion) as they can be given at higher doses (from 500 mg to more than 1000 mg/infusion). The purpose of this review is to discuss some pertinent issues in relation to the history, pharmacology, administration, efficacy, safety profile and toxicity of intravenous iron for the treatment of iron deficiency anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Up to 60% of people taking oral iron supplements report gastrointestinal side effects [10].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“patients that receive IV iron infusions report a lower occurrence of these side effects [10] such as nausea (1.6% vs. 4.9%), vomiting (1.0% vs. 6.8%), abdominal pain (1.3% vs. 7.9%), and diarrhoea (0.9% vs. 8.3%) [4].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457
Diagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 4×
“(5-8) Because of the high rate of gastrointestinal AEs (35% to 59%) with ferrous sulfate, new compounds containing either the ferric or ferrous salt forms have been developed as different preparations (amino-acid chelates, carbonyl iron, iron III polymaltose complex [IPC], extended-release products) and approved for c…”
BackgroundInfluentialGasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20285 · Cited by 450
Huang, X. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.023 · Cited by 444
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
Lu, M., Cohen, M. H., Rieves, D., & Pazdur, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21656 · Cited by 443
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Muñoz, M., Villar, I., & García-Erce, J. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4617 · Cited by 371
Self-citationKulnigg, S., Stoinov, S., Simanenkov, V., Dudar, L. V., Karnafel, W., Garcia, L. C., Sambuelli, A. M., D'Haens, G., & Gasche, C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01744.x · Cited by 349
Research works printed but not linked: 3
- [2]Hersko C Prevalence and causes of iron deficiency anaemia In: Beaumont C Beris P Beuzard Y Brugnara C Disorders of iron homeostasis, erythrocytes, erythropoiesis. Paris: European School of Haematology; 2006: 409- 19
- [4]Blaud P [Sur les maladies chloropiques et sur un mode de traitement specifique dons ces affecions]. Rev Med Fr Etrang. 1832; 45: 357- 67 French
- [59]García-Erce JA Cuenca J Gómez-Ramírez S Villar I Herrera A Muñoz M Posibilidades de tratamiento de la anemia perioperatoria en cirugía ortopédica y traumatología. Anemia. 2009; 2: 17- 27
Cited by
Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis
Zhou, B., Zhang, J.-Y., Liu, X.-S., Chen, H.-Z., Ai, Y.-L., Cheng, K., Sun, R.-Y., Zhou, D., Han, J., & Wu, Q. (2018) · Cell Research · doi:10.1038/s41422-018-0090-y · Cited by 660
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Park, H., Otte, A., & Park, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 475
Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota
Bloor, S. R., Schutte, R., & Hobson, A. R. (2021) · Microbiology Research · doi:10.3390/microbiolres12020033 · Cited by 117
“First-line treatment is recommended to be ferrous sulphate two or three times per day, totalling a daily maximum elemental iron dosage of 195 mg [9,10].”
BackgroundInfluential
Metadata
- Authors
- Cançado, R. D., & Muñoz, M.
- Affiliations
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Corresponding author
- Cançado, Rodolfo Delfini
- Venue
- Revista Brasileira de Hematologia e Hemoterapia
- Published
- 2011
- Volume
- 33
- Issue
- 6
- Pages
- 461-469
- ISSN
- 1516-8484 (ISSN-L)
- PMC
- PMC3459360
- OpenAlex
- W2109305563
- Cited by
- 94
- References
- 59
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 10 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 9 · 2017: 10 · 2016: 9 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Revista Brasileira de Hematologia e Hemoterapia (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Keywords
- intravenous iron, iron deficiency anemia, iron dextran, ferric gluconate, iron sucrose, anaphylaxis, iron toxicity, iron stores, oral iron supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous iron therapy: how far have we come? https://app.cochat.ai/papers/10.5581/1516-8484.20110123
- The paper
- Cançado, R. D., & Muñoz, M. (2011). Intravenous iron therapy: how far have we come? Revista Brasileira de Hematologia e Hemoterapia. https://doi.org/10.5581/1516-8484.20110123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.